Sector: Consumer Non-Cyclicals | Industry: Drug Retailers |
Company Contact | |
Address: | 150 York Street, #1008 Toronto TORONTO ON M5H 3S5 |
Tel: | N/A |
Website: | https://www.shinyhealthandwellness.com/overview/default.aspx |
IR: | See website |
Key People | ||
Kevin Reed Chairman of the Board | Meris Kott Interim Chief Executive Officer, Director | Micah Dass Independent Executive Vice Chairman |
Jude Pinto Chief Financial Officer, Chief Information Officer, Corporate Secretary | Josh Cooksley Executive Vice President, Corporate Development and Investor Relations |
Business Overview |
Shiny Health & Wellness Corp. is a Canada-based independent cannabis and pharmacy retailer. The Company operates ShinyBud Cannabis Co., a brand of adult-use dispensaries. ShinyBud Cannabis Co. is a multi-banner cannabis retailer with 24 corporate stores and 16 licensed stores strategically located across Ontario in markets less saturated with cannabis retailers. ShinyBud Cannabis Co. offers a range of Canadian cannabis products ranging from dried flowers, edibles, vapes, among others. The Company's other subsidiaries include SNYB Franchising Inc., Shinybud Adfund Corp, and Mihi Health and Wellness Inc. |
Financial Overview |
For the nine months ended 31 October 2023, Shiny Health & Wellness Corp revenues decreased 26% to C$16.9M. Net loss increased from C$3.8M to C$9.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Impairment - Intangibles increase from C$81K to C$6M (expense), FV/Uls Adjust on Derivatives for Hedging decrease of 94% to C$184K (income). |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $13.00M as of Oct 31, 2023 |
Annual revenue (TTM): | $23.72M as of Oct 31, 2023 |
EBITDA (TTM): | -$1.47M as of Oct 31, 2023 |
Net annual income (TTM): | -$18.06M as of Oct 31, 2023 |
Free cash flow (TTM): | -$0.26M as of Oct 31, 2023 |
Net Debt Last Fiscal Year: | $7.73M as of Oct 31, 2023 |
Shares outstanding: | 15,519,156 as of Apr 1, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |